Mereo BioPharma (MREO) Current Leases (2018 - 2026)
Mereo BioPharma (MREO) posted quarterly Current Leases of $202000.0 for Q4 2025, down 71.43% year-over-year from $707000.0 in Q4 2024, and down 49.12% quarter-over-quarter from $397000.0 in Q3 2025.
Mereo BioPharma (MREO) Current Leases (2018 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Current Leases for 8 consecutive years, with $202000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Leases fell 71.43% year-over-year to $202000.0; the TTM figure through Dec 2025 stood at $202000.0 (down 71.43% YoY), while the FY2025 annual figure was $202000.0, down 71.43% from the prior year.
- Current Leases retreated to $202000.0 in Q4 2025 per MREO's latest filing, from $397000.0 in the prior quarter.
- Across five years, Current Leases topped out at $1.0 million in Q2 2021 and bottomed at $202000.0 in Q4 2025.
- Historically, Current Leases has averaged $651505.0 across 5 years, with a median of $670500.0 in 2024.
- Annual changes were most pronounced in 2023 — Current Leases rose 19.29% — and 2025, when it tumbled 71.43%.
- Mereo BioPharma's Current Leases stood at $838462.6 in 2021, then sank by 34.81% to $546584.6 in 2022, then grew by 19.29% to $652000.0 in 2023, then climbed by 8.44% to $707000.0 in 2024, then sank by 71.43% to $202000.0 in 2025.
- Business Quant data shows MREO's Current Leases at $202000.0 in Q4 2025, $397000.0 in Q3 2025, and $601000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.08 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.11 Bn | 78.11 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.09 Bn | 50.96 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.49 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | - |
| 10 | Mereo BioPharma | 47.10 Mn | 47.10 Mn | - | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.03 Mn |
| Dec 31, 2025 | 202,000.00 |
| Sep 30, 2025 | 397,000.00 |
| Jun 30, 2025 | 601,000.00 |
| Mar 31, 2025 | 747,000.00 |
| Dec 31, 2024 | 707,000.00 |
| Sep 30, 2024 | 736,000.00 |
| Jun 30, 2024 | 679,000.00 |
| Mar 31, 2024 | 662,000.00 |
| Dec 31, 2023 | 652,000.00 |
| Jun 30, 2023 | 610,665.22 |
| Dec 31, 2022 | 546,584.60 |
| Jun 30, 2022 | 730,402.24 |
| Dec 31, 2021 | 838,462.60 |
| Jun 30, 2021 | 1.01 Mn |
| Dec 31, 2020 | 839,806.84 |
| Jun 30, 2020 | 1.11 Mn |
| Dec 31, 2019 | 3.32 Mn |
| Dec 31, 2018 | 781,067.71 |